Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Proto Labs IncPRLB · Entity 4553 | Chief Commercial Officer | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Proto Labs Inc
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,109 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 2,109 · Balance 2,109 F1: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.13 · Expires 2036-05-20 | Direct | 3,789 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 3,789 · Balance 3,789 F2: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested.
F2: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 22, 2026 20:12 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,789 | $0.00 Strike: $71.13 | $0.00 |
DisclosureSEC source: 0001628280-26-037722 · wk-form4_1779480731.xml · derivative · entry 2 Parlange Bernardo · CIK 0002135514 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,789 Underlying: Common Stock · 3,789 shares Expires 2036-05-20 F2 · derivative.exercise_date: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:12 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037722 · wk-form4_1779480731.xml · nonDerivative · entry 1 Parlange Bernardo · CIK 0002135514 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,109 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.